- Home
- AEHR vs OBIO Comparison
AEHR vs OBIO Comparison
Compare AEHR & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHR
- OBIO
- Stock Information
- Founded
- AEHR 1977
- OBIO 2017
- Country
- AEHR United States
- OBIO United States
- Employees
- AEHR N/A
- OBIO N/A
- Industry
- AEHR Electrical Products
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- AEHR Industrials
- OBIO Health Care
- Exchange
- AEHR Nasdaq
- OBIO Nasdaq
- Market Cap
- AEHR 384.9M
- OBIO 118.8M
- IPO Year
- AEHR 1997
- OBIO N/A
- Fundamental
- Price
- AEHR $14.10
- OBIO $2.96
- Analyst Decision
- AEHR
- OBIO Strong Buy
- Analyst Count
- AEHR 0
- OBIO 5
- Target Price
- AEHR N/A
- OBIO $14.20
- AVG Volume (30 Days)
- AEHR 1.8M
- OBIO 369.1K
- Earning Date
- AEHR 07-08-2025
- OBIO 08-11-2025
- Dividend Yield
- AEHR N/A
- OBIO N/A
- EPS Growth
- AEHR N/A
- OBIO N/A
- EPS
- AEHR N/A
- OBIO N/A
- Revenue
- AEHR $58,968,000.00
- OBIO $2,886,000.00
- Revenue This Year
- AEHR $26.54
- OBIO $20.47
- Revenue Next Year
- AEHR $22.05
- OBIO $11.45
- P/E Ratio
- AEHR N/A
- OBIO N/A
- Revenue Growth
- AEHR N/A
- OBIO 30.23
- 52 Week Low
- AEHR $6.27
- OBIO $2.37
- 52 Week High
- AEHR $21.44
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- AEHR 60.10
- OBIO 51.30
- Support Level
- AEHR $12.19
- OBIO $2.78
- Resistance Level
- AEHR $16.17
- OBIO $2.94
- Average True Range (ATR)
- AEHR 1.07
- OBIO 0.21
- MACD
- AEHR 0.07
- OBIO -0.00
- Stochastic Oscillator
- AEHR 63.26
- OBIO 60.87
About AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.